Alterity Therapeutics Limited (ATHE) Stock Price

3.17 ▼ -0.09 (-2.76%)
Open: 3.16 Vol: 14.52K Day's range: 3.07 - 3.2486 Jan 30, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATHE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.43▼ 3.44▼ 3.44▼ 3.38▼ 3.37▼
MA10 3.49▼ 3.42▼ 3.40▼ 3.37▼ 3.34▼
MA20 3.42▼ 3.41▼ 3.38▼ 3.35▼ 3.74▼
MA50 3.28▼ 3.24▼ 3.24▼ 3.32▼ 4.09▼
MA100 3.34▼ 3.66▼ 3.80▼ 3.83▼ 3.06▲
MA200 4.07▼ 4.10▼ 4.26▼ 4.17▼ 3.44▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.031▼ -0.019▼ -0.012▼ -0.007▼ -0.045▼
RSI 34.211▼ 37.713▼ 39.413▼ 43.011▼ 41.655▼
STOCH 56.746     65.657     65.657     49.751     52.622    
WILL %R -100.000▼ -100.000▼ -100.000▼ -84.810▼ -76.760▼
CCI -202.308▼ -163.944▼ -171.126▼ -146.338▼ -32.812    
Latest Filters Detected On ATHE
▼ MACD $ATHE MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ GAP $ATHE Open Gap Down %3 Set Alert
▼ GAP $ATHE Open Gap Down %2 Set Alert
CDL $ATHE Doji Candlestick Pattern Detected Set Alert
Alterity Therapeutics Limited News
ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
Wednesday, January 21, 2026 05:19 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
Wednesday, January 21, 2026 04:43 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...
Canaccord Genuity Initiates Coverage of Alterity Therapeutics Limited - Depositary Receipt (ATHE) with Speculative Buy Recommendation
Wednesday, December 17, 2025 04:09 PM
Fintel reports that on December 17, 2025, Canaccord Genuity initiated coverage of Alterity Therapeutics Limited - Depositary Receipt (NasdaqCM:ATHE) with a Speculative Buy recommendation. There are 17 ...
ATHE historical stock data
date open high low close volume
30/01/26 3.16 3.2486 3.07 3.17 14,516
29/01/26 3.35 3.35 3.23 3.26 11,719
28/01/26 3.49 3.51 3.32 3.38 5,883
27/01/26 3.52 3.62 3.23 3.51 38,727
26/01/26 3.55 3.84 3.49 3.57 59,766
23/01/26 3.31 3.60 3.27 3.55 25,517
22/01/26 3.26 3.32 3.26 3.27 7,014
21/01/26 3.05 3.29 3.05 3.25 15,021
20/01/26 3.30 3.37 3.30 3.30 7,250
16/01/26 3.30 3.46 3.30 3.45 13,212
Quote Details
52wk Low:2.521
52wk High:7.00
Vol:14.52K
Avg Vol(3m):304K
1Y Chng:-28.28%
1M Chng:+8.56%
Add to Watch List
More Information
Index US Composite
Market Cap. 59.09M